This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02391/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02391/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB02391/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02391/identifier/drugbank/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02391
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB02391 n11:DB02391
dcterms:title
2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One
adms:identifier
n4:445732 n10:DB02391 n12:46505395 n13:GU7
n5:IUPAC-Name
n6:271B596E-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5974-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5973-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5970-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5971-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5972-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B596C-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B596D-363D-11E5-9242-09173F13E4C5 n6:271B596A-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B596B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B597A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B597B-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5975-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5976-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5978-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5977-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5979-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5980-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5982-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5983-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B597F-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B597E-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5981-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B596F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B597C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B597D-363D-11E5-9242-09173F13E4C5